Abrysvo (PF-06928316) - Pfizer
Enflonsia (clesrovimab-cfor) - Merck (MSD)
Beyfortus (nirsevimab) - Sanofi
SiRiUS: Severe Pediatric Respiratory Syncytial Virus Infections Occurring in the Era of Antiviral Prophylaxis (clinicaltrials.gov) - Oct 27, 2026 - P=N/A | N=300 | Not yet recruiting | Sponsor: Assistance Publique - Hôpitaux de Paris 
New trial • Infectious Disease • Pediatrics • Respiratory Diseases • Respiratory Syncytial Virus Infections
http://clinicaltrials.gov/ct2/show/NCT07893652
 
Oct 27, 2026
 
Prev Next